Replies to post #212674 on Biotech Values

[DewDiligence]

Although GILD’s HCV sales rose 11% QoQ, this growth could be an artifact due to inventory adjustments and deferred recognition of revenue from prior sales:

$GILD #HCV franchise sales up ~10% QoQ, first sign of stabilizing?

Slide mention inventory build in US and deferred revenue in EU though pic.twitter.com/G0CtBe1GeE

— Andy Biotech (@AndyBiotech) July 26, 2017

That's slide #28 at the link in #msg-133326806.